Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer
Clinical trial NCT00193037 · COMPLETED
Trial details
- NCT number
- NCT00193037
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-02-01
- Primary completion
- 2008-12-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.